Chen Chen's Contact Details

Chen Chen's Company Details

Calroy Health Sciences

Scottsdale, AZ, US • 5 - 9 Employees
Healthcare Facility/Healthcare Services

Calroy Health Science's mission is to develop innovative therapies in the emerging field of the vascular endothelial glycocalyx (EG) and cardiovascular health. The focus of the company's research and product development efforts target the protection of the endothelium.Understanding that almost all cardiovascular challenges begins with injury to the endothelium, we are focused on the health of the glycocalyx, a microscopic gel-like lining that naturally protects the endothelium. When the glycocalyx is breached, cholesterol can lodge under endothelial cells, initiating the inflammatory response that leads to plaque formation and thrombotic events. It transpires that the endothelial glycocalyx is exceptionally vulnerable to collapse through poor diet, disease, stress and aging.Calroy is working with academic and medical organizations around the world to advance understanding of how to protect and restore the endothelial glycocalyx. Cellular, animal and human studies have already been conducted to understand the function of the patent-pending glycocalyx regenerating compound (GRC) used in our ground-breaking product, Arterosil HP.